86 related articles for article (PubMed ID: 19740626)
21. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
[TBL] [Abstract][Full Text] [Related]
22. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
[TBL] [Abstract][Full Text] [Related]
23. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
24. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
Snozek CL; Rollins LA; Peterson PW; Langman LJ
Ther Drug Monit; 2010 Feb; 32(1):107-11. PubMed ID: 20010458
[TBL] [Abstract][Full Text] [Related]
25. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
[TBL] [Abstract][Full Text] [Related]
26. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy.
Fröscher W; Schier KR; Hoffmann M; Meyer A; May TW; Rambeck B; Rösche J
Epileptic Disord; 2005 Sep; 7(3):237-48. PubMed ID: 16162434
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers.
Ahmed GF; Marino SE; Brundage RC; Pakhomov SV; Leppik IE; Cloyd JC; Clark A; Birnbaum AK
Br J Clin Pharmacol; 2015 May; 79(5):820-30. PubMed ID: 25403343
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
[TBL] [Abstract][Full Text] [Related]
29. Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
Christensen J; Sabers A; Sidenius P
Neurology; 2006 Oct; 67(8):1497-9. PubMed ID: 17060586
[TBL] [Abstract][Full Text] [Related]
30. Age and antiepileptic drugs influence topiramate plasma levels in children.
Dahlin MG; Ohman IK
Pediatr Neurol; 2004 Oct; 31(4):248-53. PubMed ID: 15464635
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
32. Estimation of topiramate in subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma: a single case microdialysis study.
Lindberger M; Tomson T; Ohman I; Wallstedt L; Ståhle L
Epilepsia; 1999 Jun; 40(6):800-2. PubMed ID: 10368083
[TBL] [Abstract][Full Text] [Related]
33. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
34. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
Krymchantowski AV; Jevoux CC
Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
[TBL] [Abstract][Full Text] [Related]
35. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.
Russo E; Constanti A; Ferreri G; Citraro R; De Sarro G
Neuropharmacology; 2004 May; 46(6):865-78. PubMed ID: 15033346
[TBL] [Abstract][Full Text] [Related]
36. Topiramate concentration in saliva: an alternative to serum monitoring.
Miles MV; Tang PH; Glauser TA; Ryan MA; Grim SA; Strawsburg RH; deGrauw TJ; Baumann RJ
Pediatr Neurol; 2003 Aug; 29(2):143-7. PubMed ID: 14580658
[TBL] [Abstract][Full Text] [Related]
37. Topiramate effects on plasma serotonin levels in children with epilepsy.
Grosso S; Blardi P; Battaglini M; Franzoni E; De Lalla A; Mostardini R; Balestri P
Epilepsy Res; 2008 Oct; 81(2-3):148-54. PubMed ID: 18603411
[TBL] [Abstract][Full Text] [Related]
38. Topiramate pharmacokinetics in infants and young children: contribution of population analysis.
Bouillon-Pichault M; Nabbout R; Chhun S; Rey E; Chiron C; Dulac O; Pons G; Jullien V
Epilepsy Res; 2011 Feb; 93(2-3):208-11. PubMed ID: 21256717
[TBL] [Abstract][Full Text] [Related]
39. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
40. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
